2023
DOI: 10.1016/j.cvsm.2023.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Cushing’s Syndrome and Other Causes of Insulin Resistance in Dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 33 publications
0
10
0
Order By: Relevance
“…This case challenges the classic assumption that dogs invariably have a permanent, absolute insulin deficiency at the time of DM diagnosis, 2 and supports the presence of fluctuating contributors to beta cell function or peripheral insulin resistance. Though an identifiable underlying condition to explain the dog's remission was lacking, he had historic (obesity and corticosteroid therapy), recent (feeding of table scraps, which might be high in fat), and ongoing (breed predisposition to hypercortisolism) risk factors for insulin resistance 3‐9 . The dog's relapse 1 year after insulin discontinuation suggests that his pancreatic beta cell function did not fully recover, despite his apparent ability to maintain euglycemia during the intervening period.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This case challenges the classic assumption that dogs invariably have a permanent, absolute insulin deficiency at the time of DM diagnosis, 2 and supports the presence of fluctuating contributors to beta cell function or peripheral insulin resistance. Though an identifiable underlying condition to explain the dog's remission was lacking, he had historic (obesity and corticosteroid therapy), recent (feeding of table scraps, which might be high in fat), and ongoing (breed predisposition to hypercortisolism) risk factors for insulin resistance 3‐9 . The dog's relapse 1 year after insulin discontinuation suggests that his pancreatic beta cell function did not fully recover, despite his apparent ability to maintain euglycemia during the intervening period.…”
Section: Discussionmentioning
confidence: 99%
“…Glucocorticoids are another potential source of insulin resistance 8 . Exogenous glucocorticoid therapy is associated with DM risk in dogs, 34 and there is a report of a dog with DM remission after cessation of glucocorticoid therapy 4 .…”
Section: Discussionmentioning
confidence: 99%
“…The global prevalence of CDM from published literature ranges from 0.15 to 1.33% while sex and gonadal status (entire or desexed) predisposition to CDM varies according to the population studied [ 6 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ]. However, it is generally accepted that entire females are at increased risk for CDM development due to the influence of diestrus [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 11 , 26 ]. Female dogs have a two-fold higher CDM incidence compared to males, and nearly 75% of the diagnosed dogs with DM are females [ 5 , 6 , 7 , 8 , 26 , 27 ]; however, this distribution can show a vast range.…”
Section: The Relevance Of Progesterone-related Diabetes Mellitus Subtypementioning
confidence: 99%
“…Given the heterogeneous pathogenesis of CDM, common risk factors associated with insulin-resistant diabetes (IRD) such as obesity, diestrus, hypercortisolism, hypersomatotropism, progestins, and glucocorticoid exposure can act as triggers in previously susceptible dogs [ 2 , 5 , 6 , 9 , 11 , 28 ]. Environmental factors triggering types 1 and 2 DM in humans are well understood, and potentially other environmental factors such as diet, exercise, infections, and diseases (pancreatitis, pyometra) also have a role in these complex interactions regarding CDM pathogenesis [ 2 ].…”
Section: The Relevance Of Progesterone-related Diabetes Mellitus Subtypementioning
confidence: 99%
See 1 more Smart Citation